1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cancer Diagnosis & Therapy
  • 1.2.3 Reverse Vaccinology
  • 1.2.4 Immune System Modeling
• 1.3 Market by Application
  • 1.3.1 Global Computational Immunology Market Share by Application: 2020 VS 2026
  • 1.3.2 Allergy Prediction Databases
  • 1.3.3 Analysis Resource Database
  • 1.3.4 International Immunogenetics System
  • 1.3.5 The Ontology Of Immune Epitopes
  • 1.3.6 Immune Epitope Database
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Computational Immunology Market Perspective (2015-2026)
• 2.2 Global Computational Immunology Growth Trends by Regions
  • 2.2.1 Computational Immunology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Computational Immunology Historic Market Share by Regions (2015-2020)
  • 2.2.3 Computational Immunology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Computational Immunology Players by Market Size
  • 3.1.1 Global Top Computational Immunology Players by Revenue (2015-2020)
  • 3.1.2 Global Computational Immunology Revenue Market Share by Players (2015-2020)
• 3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Computational Immunology Revenue
• 3.4 Global Computational Immunology Market Concentration Ratio
  • 3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2019
• 3.5 Key Players Computational Immunology Area Served
• 3.6 Key Players Computational Immunology Product Solution and Service
• 3.7 Date of Enter into Computational Immunology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Immunology Breakdown Data by Type (2015-2026)

• 4.1 Global Computational Immunology Historic Market Size by Type (2015-2020)
• 4.2 Global Computational Immunology Forecasted Market Size by Type (2021-2026)

5 Computational Immunology Breakdown Data by Application (2015-2026)

• 5.1 Global Computational Immunology Historic Market Size by Application (2015-2020)
• 5.2 Global Computational Immunology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Computational Immunology Market Size (2015-2026)
• 6.2 North America Computational Immunology Market Size by Type (2015-2020)
• 6.3 North America Computational Immunology Market Size by Application (2015-2020)
• 6.4 North America Computational Immunology Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Computational Immunology Market Size (2015-2026)
• 7.2 Europe Computational Immunology Market Size by Type (2015-2020)
• 7.3 Europe Computational Immunology Market Size by Application (2015-2020)
• 7.4 Europe Computational Immunology Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Computational Immunology Market Size (2015-2026)
• 8.2 China Computational Immunology Market Size by Type (2015-2020)
• 8.3 China Computational Immunology Market Size by Application (2015-2020)
• 8.4 China Computational Immunology Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Computational Immunology Market Size (2015-2026)
• 9.2 Japan Computational Immunology Market Size by Type (2015-2020)
• 9.3 Japan Computational Immunology Market Size by Application (2015-2020)
• 9.4 Japan Computational Immunology Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Computational Immunology Market Size (2015-2026)
• 10.2 Southeast Asia Computational Immunology Market Size by Type (2015-2020)
• 10.3 Southeast Asia Computational Immunology Market Size by Application (2015-2020)
• 10.4 Southeast Asia Computational Immunology Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 EpiVax
  • 11.1.1 EpiVax Company Details
  • 11.1.2 EpiVax Business Overview
  • 11.1.3 EpiVax Computational Immunology Introduction
  • 11.1.4 EpiVax Revenue in Computational Immunology Business (2015-2020))
  • 11.1.5 EpiVax Recent Development
• 11.2 Novozymes Biopharma
  • 11.2.1 Novozymes Biopharma Company Details
  • 11.2.2 Novozymes Biopharma Business Overview
  • 11.2.3 Novozymes Biopharma Computational Immunology Introduction
  • 11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2015-2020)
  • 11.2.5 Novozymes Biopharma Recent Development
• 11.3 ioGenetics
  • 11.3.1 ioGenetics Company Details
  • 11.3.2 ioGenetics Business Overview
  • 11.3.3 ioGenetics Computational Immunology Introduction
  • 11.3.4 ioGenetics Revenue in Computational Immunology Business (2015-2020)
  • 11.3.5 ioGenetics Recent Development
• 11.4 International Society of Vaccines
  • 11.4.1 International Society of Vaccines Company Details
  • 11.4.2 International Society of Vaccines Business Overview
  • 11.4.3 International Society of Vaccines Computational Immunology Introduction
  • 11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2015-2020)
  • 11.4.5 International Society of Vaccines Recent Development
• 11.5 IMGT
  • 11.5.1 IMGT Company Details
  • 11.5.2 IMGT Business Overview
  • 11.5.3 IMGT Computational Immunology Introduction
  • 11.5.4 IMGT Revenue in Computational Immunology Business (2015-2020)
  • 11.5.5 IMGT Recent Development
• 11.6 Dassault Systemes
  • 11.6.1 Dassault Systemes Company Details
  • 11.6.2 Dassault Systemes Business Overview
  • 11.6.3 Dassault Systemes Computational Immunology Introduction
  • 11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2015-2020)
  • 11.6.5 Dassault Systemes Recent Development
• 11.7 Certara
  • 11.7.1 Certara Company Details
  • 11.7.2 Certara Business Overview
  • 11.7.3 Certara Computational Immunology Introduction
  • 11.7.4 Certara Revenue in Computational Immunology Business (2015-2020)
  • 11.7.5 Certara Recent Development
• 11.8 Chemical Computing Group
  • 11.8.1 Chemical Computing Group Company Details
  • 11.8.2 Chemical Computing Group Business Overview
  • 11.8.3 Chemical Computing Group Computational Immunology Introduction
  • 11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2015-2020)
  • 11.8.5 Chemical Computing Group Recent Development
• 11.9 Compugen
  • 11.9.1 Compugen Company Details
  • 11.9.2 Compugen Business Overview
  • 11.9.3 Compugen Computational Immunology Introduction
  • 11.9.4 Compugen Revenue in Computational Immunology Business (2015-2020)
  • 11.9.5 Compugen Recent Development
• 11.10 Genedata AG
  • 11.10.1 Genedata AG Company Details
  • 11.10.2 Genedata AG Business Overview
  • 11.10.3 Genedata AG Computational Immunology Introduction
  • 11.10.4 Genedata AG Revenue in Computational Immunology Business (2015-2020)
  • 11.10.5 Genedata AG Recent Development
• 11.11 Insilico Biotechnology AG
  • 10.11.1 Insilico Biotechnology AG Company Details
  • 10.11.2 Insilico Biotechnology AG Business Overview
  • 10.11.3 Insilico Biotechnology AG Computational Immunology Introduction
  • 10.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2015-2020)
  • 10.11.5 Insilico Biotechnology AG Recent Development
• 11.12 Leadscope Inc
  • 10.12.1 Leadscope Inc Company Details
  • 10.12.2 Leadscope Inc Business Overview
  • 10.12.3 Leadscope Inc Computational Immunology Introduction
  • 10.12.4 Leadscope Inc Revenue in Computational Immunology Business (2015-2020)
  • 10.12.5 Leadscope Inc Recent Development
• 11.13 Nimbus Discovery
  • 10.13.1 Nimbus Discovery Company Details
  • 10.13.2 Nimbus Discovery Business Overview
  • 10.13.3 Nimbus Discovery Computational Immunology Introduction
  • 10.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2015-2020)
  • 10.13.5 Nimbus Discovery Recent Development
• 11.14 Strand Life Sciences
  • 10.14.1 Strand Life Sciences Company Details
  • 10.14.2 Strand Life Sciences Business Overview
  • 10.14.3 Strand Life Sciences Computational Immunology Introduction
  • 10.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2015-2020)
  • 10.14.5 Strand Life Sciences Recent Development
• 11.15 Schrodinger
  • 10.15.1 Schrodinger Company Details
  • 10.15.2 Schrodinger Business Overview
  • 10.15.3 Schrodinger Computational Immunology Introduction
  • 10.15.4 Schrodinger Revenue in Computational Immunology Business (2015-2020)
  • 10.15.5 Schrodinger Recent Development
• 11.16 Simulation Plus
  • 10.16.1 Simulation Plus Company Details
  • 10.16.2 Simulation Plus Business Overview
  • 10.16.3 Simulation Plus Computational Immunology Introduction
  • 10.16.4 Simulation Plus Revenue in Computational Immunology Business (2015-2020)
  • 10.16.5 Simulation Plus Recent Development
• 11.17 Rosa & Co
  • 10.17.1 Rosa & Co Company Details
  • 10.17.2 Rosa & Co Business Overview
  • 10.17.3 Rosa & Co Computational Immunology Introduction
  • 10.17.4 Rosa & Co Revenue in Computational Immunology Business (2015-2020)
  • 10.17.5 Rosa & Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Computational Immunology Scope and Market Size
Computational Immunology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Computational Immunology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Market segment by Application, split into
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database

Based on regional and country-level analysis, the Computational Immunology market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Computational Immunology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co